SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001315863-24-000253
Filing Date
2024-02-14
Accepted
2024-02-14 10:50:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 esperion_sc13ga_1.htm SC 13G/A 87349
  Complete submission text file 0001315863-24-000253.txt   89081
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87536 | Film No.: 24633947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 32 ELM PLACE, 3RD FLOOR RYE NY 10580
Business Address 32 ELM PLACE, 3RD FLOOR RYE NY 10580 917.536.6028
Two Seas Capital LP (Filed by) CIK: 0001823138 (see all company filings)

IRS No.: 843799363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A